Accord Seeks To Capitalize On Portfolio And Partnerships

Company Points To Growth That Outperforms Peers

 
• By David Wallace
  
Portfolio button keyboard
Accord’s portfolio covers generics, biosimilars, value-added products and brands • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business